I have been on the faculty of Memorial Sloan-Kettering since 1989, and over the years I have treated thousands of people with common as well as rare gastrointestinal cancers. I have particular expertise in managing cancers of the colon and rectum, as well as rare tumors of the digestive tract such as carcinoid and pancreatic neuroendocrine tumors, and other digestive tract cancers such as liver, pancreas, stomach, and esophagus cancers. I also treat other neuroendocrine tumors such as adrenal cancers and pheochromocytomas.
Much of my career has also been dedicated to developing new drug therapies and treatment strategies for colorectal cancer, and I have tapped the vast resources of Memorial Sloan-Kettering — from various clinical departments to the Human Oncology and Pathogenesis Program, the Sloan-Kettering Institute, and The Rockefeller University — to create an integrated translational research program. As Chief of the Gastrointestinal Medical Oncology Service, I look forward to expanding this program even more in the years to come. I see enormous potential in using recent advances in the molecular analysis of tumors from individual patients to personalize and improve cancer treatment.